Clinical Trials

66 enrolled

Adenocarcinoma, Carcinoma, Rectal Neoplasms, Colorectal Neoplasms

NCT07455422 2026-03-06

Endeavor-2

266 enrolled

Adenocarcinoma, Barrett Esophagus

NCT07444983 2026-03-03

Rezvilutamide for High-Risk Prostate Cancer After Surgery

33 enrolled

Adenocarcinoma, Prostatic Neoplasms

NCT07385703 2026-02-04

Clinical Study on the Efficacy and Safety of LM-302 Injection Combined With Tislelizumab and Tislelizumab Combined Chemotherapy for the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma.

752 enrolled

Tumor-Agnostic

Adenocarcinoma

NCT07368985 2026-01-27

Pembrolizumab and Lenvatinib in Patients With High Risk Locally Advanced Cervix Cancer

Phase 1/2 Not yet recruiting

87 enrolled

Gynecologic

Adenocarcinoma, Uterine Cervical Neoplasms

NCT06906471 2026-01-22

A Single-Arm, Blinded, Fluorescent PSMA Histopathology Trial of AS1986NS

10 enrolled

Phase 1 Not yet recruiting

Adenocarcinoma, Prostatic Neoplasms

NCT07316686 2026-01-05

Lutécio

18 enrolled

Adenocarcinoma, Prostatic Neoplasms

NCT07268794 2025-12-08

CONVERT-HB1

112 enrolled

Adenocarcinoma, Prostatic Neoplasms

NCT06794073 2025-08-29

Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Clinical Study

17 enrolled

Phase 1 Not yet recruiting

Adenocarcinoma, Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasms, Glandular and Epithelial

NCT07117214 2025-08-12

A Phase I Study of [68Ga]Ga-DWJ155 in Patients With Breast and Lung Cancers

36 enrolled

BreastThoracic

Adenocarcinoma, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT07118800 2025-08-12

NACRE-2

160 enrolled

Tumor-Agnostic

Adenocarcinoma

NCT06942767 2025-04-27

Combination of QLS31905, QL2107 and Chemotherapy as First-line Therapy in CLDN18.2-positive Unresectable Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

100 enrolled

Tumor-Agnostic

Adenocarcinoma

NCT06931496 2025-04-17

PROSTIA- BP

150 enrolled

Adenocarcinoma, Prostatic Neoplasms

NCT06915909 2025-04-08

Robotic Prostatectomy Artificial Intelligence Low Pressure Pain (RALP) Trial

40 enrolled

Adenocarcinoma, Pain, Pain, Postoperative, Prostatic Neoplasms

NCT06855589 2025-03-04

PCS-XII

400 enrolled

Adenocarcinoma, Prostatic Neoplasms

NCT06844513 2025-02-25

URO-ROBOT-2023

800 enrolled

Adenocarcinoma, Kidney Neoplasms, Prostatic Neoplasms

NCT06469060 2024-07-01

TRACE

34 enrolled

Adenocarcinoma, Esophageal Neoplasms

NCT06241469 2024-02-05

Efficacy and Safety of Sintilimab Combined With Nab-paclitaxel and Tegio (aTS) as First-line Treatment of Unresectable Locally Advanced, Recurrent or Metastatic Adenocarcinoma of Gastric and Gastroesophageal Junction，a Phase II Clinical Study

40 enrolled

Adenocarcinoma, Stomach Neoplasms

NCT04384601 2021-07-19

Dragon III-Phase 3: Neoadjuvant Chemotherapy (FLOT Versus SOX) for Gastric Cancer

246 enrolled